Search research articles
Contact Us
Filters
Showing results (461-470 of 474) with videos related to
Page
of 48
Sort By:
Annals of Translational Medicine
|
March 12, 2021
Primary tumor immune score fails to predict the prognosis of colorectal cancer liver metastases after hepatectomy in Chinese populations
Hao-Cheng Lin, Qiong Shao, Jie-Ying Liang, et al.
Journal of Asian Natural Products Research
|
March 12, 2025
Lifei Qingchang Tang attenuates acute lung injury <i>via</i> the NF-κB and MAPK signaling pathways
Qi-Fen Huang, Jia-Min Zeng, Yuan-Long Hu, et al.
Ophthalmology
|
October 7, 2021
Digital Gonioscopy Based on Three-dimensional Anterior-Segment OCT: An International Multicenter Study
Fei Li, Yifan Yang, Xu Sun, et al.
Signal Transduction and Targeted Therapy
|
September 21, 2023
Dynamic single-cell mapping unveils Epstein‒Barr virus-imprinted T-cell exhaustion and on-treatment response
Miao-Zhen Qiu, Chaoye Wang, Zhiying Wu, et al.
Gut
|
October 1, 2018
Liquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer
De-Shen Wang, Ze-Xian Liu, Yun-Xin Lu, et al.
Signal Transduction and Targeted Therapy
|
September 9, 2020
VDR-SOX2 signaling promotes colorectal cancer stemness and malignancy in an acidic microenvironment
Pei-Shan Hu, Ting Li, Jin-Fei Lin, et al.
Cancer Chemotherapy and Pharmacology
|
December 4, 2016
Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway
Ming-Ming He, Dong-Sheng Zhang, Feng Wang, et al.
Nature Medicine
|
March 4, 2024
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial
Feng Wang, Ying Jin, Min Wang, et al.
Cancer Cell
|
July 25, 2025
Alistipes finegoldii augments the efficacy of immunotherapy against solid tumors
Zhi-Ying Wu, Qi-Wen Wu, Yi Han, et al.
BMJ (Clinical Research Ed.)
|
May 28, 2024
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial
Miao-Zhen Qiu, Do-Youn Oh, Ken Kato, et al.
Page
of 48
Search research articles
Search
Showing results (461-470 of 474) with videos related to
Sort By:
Page
of 48
Annals of Translational Medicine
|
March 12, 2021
Primary tumor immune score fails to predict the prognosis of colorectal cancer liver metastases after hepatectomy in Chinese populations
Hao-Cheng Lin, Qiong Shao, Jie-Ying Liang, et al.
Journal of Asian Natural Products Research
|
March 12, 2025
Lifei Qingchang Tang attenuates acute lung injury <i>via</i> the NF-κB and MAPK signaling pathways
Qi-Fen Huang, Jia-Min Zeng, Yuan-Long Hu, et al.
Ophthalmology
|
October 7, 2021
Digital Gonioscopy Based on Three-dimensional Anterior-Segment OCT: An International Multicenter Study
Fei Li, Yifan Yang, Xu Sun, et al.
Signal Transduction and Targeted Therapy
|
September 21, 2023
Dynamic single-cell mapping unveils Epstein‒Barr virus-imprinted T-cell exhaustion and on-treatment response
Miao-Zhen Qiu, Chaoye Wang, Zhiying Wu, et al.
Gut
|
October 1, 2018
Liquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer
De-Shen Wang, Ze-Xian Liu, Yun-Xin Lu, et al.
Signal Transduction and Targeted Therapy
|
September 9, 2020
VDR-SOX2 signaling promotes colorectal cancer stemness and malignancy in an acidic microenvironment
Pei-Shan Hu, Ting Li, Jin-Fei Lin, et al.
Cancer Chemotherapy and Pharmacology
|
December 4, 2016
Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway
Ming-Ming He, Dong-Sheng Zhang, Feng Wang, et al.
Nature Medicine
|
March 4, 2024
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial
Feng Wang, Ying Jin, Min Wang, et al.
Cancer Cell
|
July 25, 2025
Alistipes finegoldii augments the efficacy of immunotherapy against solid tumors
Zhi-Ying Wu, Qi-Wen Wu, Yi Han, et al.
BMJ (Clinical Research Ed.)
|
May 28, 2024
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial
Miao-Zhen Qiu, Do-Youn Oh, Ken Kato, et al.
Page
of 48